Evidence map›Paper›PMID 26514920›Full record

ArticleBMC medical research methodology2015

The need to balance merits and limitations from different disciplines when considering the stepped wedge cluster randomized trial design.

Esther de Hoop, Ingeborg van der Tweel, Rieke van der Graaf, Karel G M Moons, Johannes J M van Delden, Johannes B Reitsma, Hendrik Koffijberg

Abstract read
In one paragraph

Article in BMC medical research methodology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Implementation of Coach McLungsBMC medical informatics and decision making · 2022
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Esther de HoopDepartment of Biostatistics and Research Support, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. E.oomen.dehoop@gmail.com.
Ingeborg van der TweelDepartment of Biostatistics and Research Support, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. I.vanderTweel@umcutrecht.nl.
Rieke van der GraafDepartment of Medical Humanities, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. R.vanderGraaf@umcutrecht.nl.
Karel G M MoonsDepartment of Epidemiology, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. K.G.M.Moons@umcutrecht.nl.
Johannes J M van DeldenDepartment of Medical Humanities, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. J.J.M.vanDelden@umcutrecht.nl.
Johannes B ReitsmaDepartment of Epidemiology, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. J.B.Reitsma-2@umcutrecht.nl.
Hendrik KoffijbergDepartment of Health Technology Assessment, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, PO Box 85500, Utrecht, 3508, GA, The Netherlands. H.Koffijberg@umcutrecht.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVarious papers have addressed pros and cons of the stepped wedge cluster randomized trial design (SWD). However, some issues have not or only limitedly been addressed. Our aim was to provide a comprehensive overview of all merits and limitations of the SWD to assist researchers, reviewers and medical ethics committees when deciding on the appropriateness of the SWD for a particular study.

methodsWe performed an initial search to identify articles with a methodological focus on the SWD, and categorized and discussed all reported advantages and disadvantages of the SWD. Additional aspects were identified during multidisciplinary meetings in which ethicists, biostatisticians, clinical epidemiologists and health economists participated. All aspects of the SWD were compared to the parallel group cluster randomized design. We categorized the merits and limitations of the SWD to distinct phases in the design and conduct of such studies, highlighting that their impact may vary depending on the context of the study or that benefits may be offset by drawbacks across study phases. Furthermore, a real-life illustration is provided.

resultsNew aspects are identified within all disciplines. Examples of newly identified aspects of an SWD are: the possibility to measure a treatment effect in each cluster to examine the (in)consistency in effects across clusters, the detrimental effect of lower than expected inclusion rates, deviation from the ordinary informed consent process and the question whether studies using the SWD are likely to have sufficient social value. Discussions are provided on e.g. clinical equipoise, social value, health economical decision making, number of study arms, and interim analyses.

conclusionsDeciding on the use of the SWD involves aspects and considerations from different disciplines not all of which have been discussed before. Pros and cons of this design should be balanced in comparison to other feasible design options as to choose the optimal design for a particular intervention study.

Indexed as

Epidemiologic MethodsResearch DesignChest PainDecision MakingHeart DiseasesHumansInformed ConsentPatient SelectionRandomized Controlled Trials as TopicSample Size

Identifiers

PMID26514920
PMCPMC4627408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.